NEW YORK and SAN RAFAEL, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Wandercraft today announced the acquisition of Ekso Bionics, Inc. from a subsidiary of ChronoScale Holdings Corporation (Nasdaq: CHRN), bringing together two leaders in robotic mobility. The two companies contribute complementary technologies and decades of combined experience to help more people to stand, walk, and participate more fully in everyday life.

纽约和加利福尼亚州圣拉斐尔，2026年10月1日（环球社讯）——Wandercraft今日宣布从ChronoScale Holdings Corporation（纳斯达克股票代码：CHRN）的子公司手中收购Ekso Bionics, Inc.，将两家机器人移动领域的领军企业合二为一。两家公司贡献互补的技术和数十年的综合经验，帮助更多人站立、行走，并更充分地参与日常生活。

Together, they form the world’s leading medical exoskeleton company, offering an unmatched combination of technology, clinical experience, and global reach..

他们共同组成了全球领先的医疗外骨骼公司，提供技术、临床经验和全球覆盖范围的无与伦比的组合。

The acquisition combines Wandercraft’s expertise in advanced robotics and physical AI and its leadership in EMEA with Ekso Bionics’ strong U.S. presence, extensive clinical experience, and commercial reach. Both companies have been trailblazers in medical exoskeletons, driving technological innovation, R&D, and clinical research.

此次收购将Wandercraft在先进机器人和物理人工智能领域的专业知识及其在EMEA地区的领导地位，与Ekso Bionics在美国的强大市场存在、广泛的临床经验以及商业覆盖范围相结合。两家公司均为医疗外骨骼领域的先驱，推动了技术创新、研发和临床研究。

The combination creates a global powerhouse in robotic mobility, with a broader portfolio of medical exoskeletons spanning the continuum of care, from rehabilitation to everyday personal mobility..

此次合并打造了一家全球领先的机器人移动解决方案巨头，其医疗外骨骼产品组合更加丰富，覆盖从康复训练到日常个人行动辅助的全程护理需求。

“We share a vision for how robotics can empower people whose mobility has been unfairly limited by injury or disease,” said Matthieu Masselin, CEO and co-founder of Wandercraft. “Both companies have pioneered advanced technologies to help people stand, walk, and participate more fully in everyday life.

“我们对于机器人技术如何赋能那些因伤病而不公地受限的行动不便者，有着共同的愿景。”Wandercraft 首席执行官兼联合创始人马蒂厄·马瑟兰表示，“两家公司均率先开发出先进技术，帮助人们站立、行走，并更充分地参与日常生活。”

By bringing together our products, teams, and clinical relationships on both sides of the Atlantic, we have an exceptional opportunity to expand access to robotic mobility worldwide, reach more patients and rehabilitation professionals, and help more people experience the independence and connection that upright mobility can offer.”.

通过整合我们在大西洋两岸的产品、团队和临床关系，我们拥有一个非凡的机遇，可以在全球范围内扩大机器人移动技术的可及性，惠及更多患者和康复专业人士，并帮助更多人体验直立移动所能带来的独立性与社会连接。

Atalante X and EksoNR currently support patients in standing and walking at more than 700 rehabilitation centers worldwide. Together, these complementary platforms hold U.S. FDA clearances and CE marking covering stroke, spinal cord injury, multiple sclerosis, and acquired brain injury. For personal use, Eve brings Wandercraft’s hands-free, self-balancing technology into the home, while Indego Personal offers a modular wearable exoskeleton.

Atalante X 和 EksoNR 目前在全球700多家康复中心支持患者进行站立和行走训练。这两款互补平台共同拥有美国FDA许可和CE认证，适用范围涵盖中风、脊髓损伤、多发性硬化症以及获得性脑损伤。在个人使用方面，Eve将Wandercraft的免提自平衡技术带入家庭环境，而Indego Personal则提供模块化的可穿戴外骨骼。

Each serves eligible individuals with spinal cord injuries, providing tailored approaches to upright mobility that align with their needs and goals. Wandercraft intends to continue supporting all four products, as well as the customers, clinicians, and individuals who rely on them..

每款产品都服务于符合条件的脊髓损伤患者，提供与其需求和目标相一致的定制化直立移动解决方案。Wandercraft 打算继续支持所有四款产品，以及依赖这些产品的客户、临床医生和使用者。

“Ekso has spent two decades pioneering robotic technologies, advancing engineering and R&D, and building a robust body of clinical research and evidence that has earned the trust of clinicians and the people who rely on our products,” said Scott Davis, of the go-forward Ekso Bionics. “Joining Wandercraft represents an exciting next chapter, uniting two organizations with a shared commitment to mobility, rehabilitation, and innovation.

“Ekso 在二十年间始终走在机器人技术的前沿，不断推进工程研发，并构建了扎实的临床研究体系与证据基础，从而赢得了临床医生及依赖我们产品的用户的信任。”即将加入新 Ekso Bionics 的 Scott Davis 表示。“携手 Wandercraft 标志着令人振奋的新篇章，将两家在移动能力、康复和创新方面拥有共同承诺的组织紧密联合在一起。”

Together, we can build on that trailblazing work and expand our ability to develop and deploy technologies that make a meaningful difference for more people.”.

我们可以携手在这一开创性工作的基础上再接再厉，提升我们开发和部署技术的能力，为更多人带来切实而有意义的改变。

The acquisition also reinforces Wandercraft’s strength in expanding market access and efficiently deploying personal exoskeletons worldwide. Patients are already receiving training at the Walk in New York by Wandercraft rehabilitation center, and a dedicated access team helps users and their care teams navigate benefits, documentation, reimbursement, financing, and coordination with clinicians and payers.

此次收购也进一步巩固了Wandercraft在扩大市场准入和高效部署个人外骨骼设备方面的全球实力。患者已经在纽约的Wandercraft康复中心接受训练，专门的准入团队帮助用户及其护理团队处理福利、文件、报销、融资以及与临床医生和支付方的协调事宜。

For individuals in the U.S. who meet eligibility and medical necessity requirements, Medicare covers qualifying personal exoskeletons under its brace benefit category, billed under HCPCS code K1007. With greater scale, the combined company will also advocate for broader coverage worldwide..

对于符合资格和医疗必要性要求的美国个人，医疗保险在其支具福利类别下承保符合条件的个人外骨骼，使用HCPCS代码K1007进行计费。随着规模扩大，合并后的公司还将倡导在全球范围内实现更广泛的覆盖。

The combination also enhances customer service through a broader international network and shared clinical expertise. For example, rehabilitation centers can now consult specialists with expertise in both Atalante X and EksoNR to identify the best solutions for their patients while maintaining dedicated, product-specific support..

此次合并还通过更广泛的国际网络和共享的临床专业知识提升了客户服务。例如，康复中心现在可以向兼具 Atalante X 和 EksoNR 专业知识的专家咨询，在保持针对特定产品的专属支持的同时，为患者确定最佳解决方案。

The boards of directors of Wandercraft and ChronoScale Holdings Corporation unanimously approved the transaction, which was signed and closed simultaneously. Financial terms were not disclosed.

Wandercraft 和 ChronoScale Holdings Corporation 的董事会一致批准了该交易，签约与交割同步完成。财务条款未予披露。

About Wandercraft

关于Wandercraft

Wandercraft is a global robotics company with a proprietary physical AI platform spanning medical and industrial applications. Eve™, its FDA-cleared personal exoskeleton, supports hands-free upright mobility for personal use, while Atalante X™ is used in more than 150 rehabilitation and research centers worldwide.

Wandercraft 是一家全球性机器人公司，拥有专有的物理人工智能平台，涵盖医疗和工业应用。其获得美国食品药品监督管理局（FDA）许可的个人外骨骼 Eve™ 支持个人免提直立移动，而 Atalante X™ 已在全球超过 150 家康复和研究机构中投入使用。

Wandercraft also applies its robotics expertise to industrial humanoid systems, including Calvin-40™, a powerful autonomous humanoid designed for heavy lifting and difficult-to-staff work. Learn more at .

Wandercraft 还将其机器人技术专长应用于工业人形系统，包括 Calvin-40™，这是一款专为重型搬运和人力短缺岗位设计的强大自主人形机器人。了解更多请访问 。

Wandercraft.eu

Wandercraft.eu

.

。

About Ekso Bionics

关于 Ekso Bionics

Ekso Bionics, Inc. is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Based upon its industry-leading expertise, the Company focuses on improving health and quality of life with advanced robotics designed to enhance, amplify, and restore human function.

Ekso Bionics, Inc. 是外骨骼解决方案的领先开发商，通过在医疗和工业应用中支持或增强力量、耐力和行动能力，从而放大人类潜能。凭借行业领先的专业技术，公司专注于利用先进的机器人技术来改善健康和生活质量，这些技术旨在增强、放大和恢复人体功能。

Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area. For more information, visit: .

Ekso Bionics 是唯一已知的外骨骼公司，提供从帮助瘫痪患者站立和行走，到增强全球各地工作场所人员能力的广泛技术。公司总部位于旧金山湾区。欲了解更多信息，请访问：。

www.eksobionics.com

www.eksobionics.com

.

。

Media Contact

媒体联系人

Wandercraft:

漫游工艺：

Sarah Jallot

莎拉·贾洛

Global Growth at Wandercraft

Wandercraft 的全球增长

Sarah.Jallot@wandercraft.health

Sarah.Jallot@wandercraft.health